NIH-funded research Sbir 2 grant

A test to identify harmful chemicals that can damage skin.

Official title: An In Chemico Test to Identify Dermal Corrosives

Funded at Lebrun Labs, LLC · NIH-11268301 · Data updated 2026-11-12

This study is working on a new way to quickly and safely identify harmful chemicals that can damage your skin, without using animals for testing, so that products can be made safer for everyone.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionLebrun Labs, LLC
NIH-funded
Lab location1 site (Anaheim, United States)
Project startApril 15, 2024
Project endMarch 31, 2027
Funding year2025
Award (this year)$618,652
NIH project number4R44ES036065-02
Project IDNIH-11268301 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who work in industries that handle hazardous chemicals or are involved in the transport of such materials.

Less likely to help

Patients who are not exposed to chemicals or do not work in environments where dermal corrosives are present may not benefit from this research.

What this research studies

This research focuses on developing a non-animal test to identify dermal corrosives, which are chemicals that can cause skin damage. The approach involves using a proprietary molecular marker that changes when exposed to corrosive substances, allowing for a quick and accurate assessment of potential skin hazards. The test is designed to be high-throughput and can be used both in laboratories and in the field, making it accessible for various applications. By eliminating the need for animal testing, this research aligns with new regulations aimed at reducing animal use in product testing.

Why it matters

Potential benefit: If successful, this research could lead to safer chemical handling and transportation, reducing the risk of skin injuries for workers and consumers.

How similar studies have gone: Other research has shown promise in developing non-animal testing methods for chemical safety, indicating that this approach could be viable.

Where this research is happening

  • Lebrun Labs, LLC
    Anaheim, United States
    Active

Researchers

  • Principal investigator: Lebrun, Stewart — Lebrun Labs, LLC
  • Study coordinator: Lebrun, Stewart

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.